Characterisation of Relative Bioavailability and Assessment of Bioequivalence of a Newly Developed Ethinylestradiol/Dienogest IR Formulation in Comparison With a Marketed Reference Product (Valette).
Phase of Trial: Phase IV
Latest Information Update: 22 May 2012
At a glance
- Drugs Ethinylestradiol/dienogest (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- 22 May 2012 New trial record